recombinant human cd36 Search Results


human recombinant cd36  (R&D Systems)
91
R&D Systems human recombinant cd36
Human Recombinant Cd36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human recombinant cd36/product/R&D Systems
Average 91 stars, based on 1 article reviews
human recombinant cd36 - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier
recombinant human cd36 fc  (R&D Systems)
91
R&D Systems recombinant human cd36 fc
Recombinant Human Cd36 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human cd36 fc/product/R&D Systems
Average 91 stars, based on 1 article reviews
recombinant human cd36 fc - by Bioz Stars, 2026-05
91/100 stars
  Buy from Supplier
cd36  (R&D Systems)
94
R&D Systems cd36
Fig. 4. C1s inhibits binding of IT4var20 IE to EPCR and IT4var13 IE binding to <t>CD36</t> but not ICAM-1. (A) Binding of IT4var20 IEs to EPCR in the absence or presence of C1s (100 μg/mL). Recombinant EPCR (rEPCR) was included as a control and indicator of how well C1s treatment abrogated IT4var20 binding to EPCR. (B) Binding of IT4var13 IEs to CD36 or ICAM-1 in the absence or presence of C1s (100 μg/mL). In both binding assays, bovine serum albumin (BSA) was included as a negative control. The mean and SEM are shown, and each data point is from an independent experiment. For statistical testing, all mean values were log-transformed, and a two-tailed unpaired t test was conducted to compare experimental groups to the positive control (EPCR only). (C) Var gene transcript levels relative to the housekeeping control gene, seryl-t-transferase, confirming the major var types being expressed as IT4var20 and IT4var13. *P < 0.05; **P < 0.01; ns, not significant.
Cd36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd36/product/R&D Systems
Average 94 stars, based on 1 article reviews
cd36 - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
vitro o glcnacylation assay  (OriGene)
90
OriGene vitro o glcnacylation assay
Fig. 4. C1s inhibits binding of IT4var20 IE to EPCR and IT4var13 IE binding to <t>CD36</t> but not ICAM-1. (A) Binding of IT4var20 IEs to EPCR in the absence or presence of C1s (100 μg/mL). Recombinant EPCR (rEPCR) was included as a control and indicator of how well C1s treatment abrogated IT4var20 binding to EPCR. (B) Binding of IT4var13 IEs to CD36 or ICAM-1 in the absence or presence of C1s (100 μg/mL). In both binding assays, bovine serum albumin (BSA) was included as a negative control. The mean and SEM are shown, and each data point is from an independent experiment. For statistical testing, all mean values were log-transformed, and a two-tailed unpaired t test was conducted to compare experimental groups to the positive control (EPCR only). (C) Var gene transcript levels relative to the housekeeping control gene, seryl-t-transferase, confirming the major var types being expressed as IT4var20 and IT4var13. *P < 0.05; **P < 0.01; ns, not significant.
Vitro O Glcnacylation Assay, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vitro o glcnacylation assay/product/OriGene
Average 90 stars, based on 1 article reviews
vitro o glcnacylation assay - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
recombinant human cd36 gst (n-term) protein  (Novus Biologicals)
N/A
Recombinant Human CD36 GST (N-Term) Protein
   Buy from Supplier
recombinant human cd36 sr b3 fc chimera protein cf  (R&D Systems)
N/A
The Recombinant Human CD36 SR B3 Fc Chimera Protein from R D Systems is derived from Sf 21 baculovirus The Recombinant Human CD36 SR B3 Fc Chimera Protein has been validated for the following applications
   Buy from Supplier
recombinant human platelet membrane glycoprotein iv/cd36/sr-b3 fc chimera protein  (Elabscience Biotechnology)
N/A
Platelet Glycoprotein 4 (CD36) is an integral membrane glycoprotein that has multiple physiological functions. It is broadly expressed on a variety of cell types including microvascular endothelium, adipocytes, skeletal muscle, epithelial cells of the retina,
   Buy from Supplier
cd36 nm 001127444 human recombinant protein  (OriGene)
N/A
Purified recombinant protein of Homo sapiens CD36 molecule thrombospondin receptor CD36 transcript variant 5
   Buy from Supplier
cd36 nm 000072 human recombinant protein  (OriGene)
N/A
Recombinant protein of human CD36 molecule thrombospondin receptor CD36 transcript variant 3
   Buy from Supplier
cd36 protein, human, recombinant (his & avi), biotinylated  (TargetMol)
N/A
   Buy from Supplier
recombinant anti-human cd36 antibody scfv fragment  (Creative BioMart)
N/A
Recombinant Mouse Antibody scFv Fragment binds selectively to Human CD36, expressed in E. coli.Used for immunoassay techniques such as: Enzyme-linked Immunosorbent Assay; Western blot; Immunofluorescence; Functional Study≤6 months at 4°C; ≥6 months at -20°C.http://www.creativebiolabs.net/Recombinant-Anti-human-CD36-Antibody-scFv-Fragment-1295.htm
   Buy from Supplier
recombinant human cd36 sr b3 protein  (Novus Biologicals)
N/A
The Recombinant Human CD36 SR B3 Protein has been validated for the following applications Western Blot ELISA Protein Array Immunoaffinity Purification
   Buy from Supplier

Image Search Results


Fig. 4. C1s inhibits binding of IT4var20 IE to EPCR and IT4var13 IE binding to CD36 but not ICAM-1. (A) Binding of IT4var20 IEs to EPCR in the absence or presence of C1s (100 μg/mL). Recombinant EPCR (rEPCR) was included as a control and indicator of how well C1s treatment abrogated IT4var20 binding to EPCR. (B) Binding of IT4var13 IEs to CD36 or ICAM-1 in the absence or presence of C1s (100 μg/mL). In both binding assays, bovine serum albumin (BSA) was included as a negative control. The mean and SEM are shown, and each data point is from an independent experiment. For statistical testing, all mean values were log-transformed, and a two-tailed unpaired t test was conducted to compare experimental groups to the positive control (EPCR only). (C) Var gene transcript levels relative to the housekeeping control gene, seryl-t-transferase, confirming the major var types being expressed as IT4var20 and IT4var13. *P < 0.05; **P < 0.01; ns, not significant.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Complement C1s cleaves PfEMP1 at interdomain conserved sites inhibiting Plasmodium falciparum cytoadherence.

doi: 10.1073/pnas.2104166118

Figure Lengend Snippet: Fig. 4. C1s inhibits binding of IT4var20 IE to EPCR and IT4var13 IE binding to CD36 but not ICAM-1. (A) Binding of IT4var20 IEs to EPCR in the absence or presence of C1s (100 μg/mL). Recombinant EPCR (rEPCR) was included as a control and indicator of how well C1s treatment abrogated IT4var20 binding to EPCR. (B) Binding of IT4var13 IEs to CD36 or ICAM-1 in the absence or presence of C1s (100 μg/mL). In both binding assays, bovine serum albumin (BSA) was included as a negative control. The mean and SEM are shown, and each data point is from an independent experiment. For statistical testing, all mean values were log-transformed, and a two-tailed unpaired t test was conducted to compare experimental groups to the positive control (EPCR only). (C) Var gene transcript levels relative to the housekeeping control gene, seryl-t-transferase, confirming the major var types being expressed as IT4var20 and IT4var13. *P < 0.05; **P < 0.01; ns, not significant.

Article Snippet: Plastic plates were spotted with 5 μL of EPCR (13320-H02H; Sino Biologicals), CSA (a gift from Dr. Michal Fried, NIAID/NIH, Bethesda, MD), CD36 (1955-CD; R&D Systems), or ICAM-1 (720-IC; R&D Systems); all recombinant proteins, except for ICAM-1 which was used at 100 μg/mL, were at a concentration of 50 μg/mL.

Techniques: Binding Assay, Recombinant, Control, Negative Control, Transformation Assay, Two Tailed Test, Positive Control

Fig. 6. Analysis of C1s-treated recombinant PfEMP1. (A) SDS/PAGE gel showing two representative PfEMP1 CIDR domains (EPCR-binding IT4var19 CIDRα1 and CD36-binding CIDRα3) and two EPCR-binding head-structure domain complexes (PFD1235w [NTSA-DBLα1-CIDRα1] and IT4var20 [NTSA-DBLα1-CIDRα1]) before and after treatment with 50 nM C1s at 1:1 molar ratio for 1 h at 37 °C. No proteolysis was seen. (B) ELISA data showing the effect of 50 nM C1s pretreatment on binding of recombinant PfEMP1 proteins to coated EPCR, CD36, or ICAM-1 (filled boxes) versus EPCR binding to coated recombinant PfEMP1 (hashed boxes). Whereas C1s treatment reduced binding activity of full-length PfEMP1 ectodomains, recombinant PfEMP1 head structure domains are insensitive to C1s treatment, indicating that C1s cleavage sites are located in the interdomain regions, consistent with MS analysis. As a control, C1s treatment of EPCR did not affect its binding to full-length PfEMP1 ectodomains (hashed boxes).

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Complement C1s cleaves PfEMP1 at interdomain conserved sites inhibiting Plasmodium falciparum cytoadherence.

doi: 10.1073/pnas.2104166118

Figure Lengend Snippet: Fig. 6. Analysis of C1s-treated recombinant PfEMP1. (A) SDS/PAGE gel showing two representative PfEMP1 CIDR domains (EPCR-binding IT4var19 CIDRα1 and CD36-binding CIDRα3) and two EPCR-binding head-structure domain complexes (PFD1235w [NTSA-DBLα1-CIDRα1] and IT4var20 [NTSA-DBLα1-CIDRα1]) before and after treatment with 50 nM C1s at 1:1 molar ratio for 1 h at 37 °C. No proteolysis was seen. (B) ELISA data showing the effect of 50 nM C1s pretreatment on binding of recombinant PfEMP1 proteins to coated EPCR, CD36, or ICAM-1 (filled boxes) versus EPCR binding to coated recombinant PfEMP1 (hashed boxes). Whereas C1s treatment reduced binding activity of full-length PfEMP1 ectodomains, recombinant PfEMP1 head structure domains are insensitive to C1s treatment, indicating that C1s cleavage sites are located in the interdomain regions, consistent with MS analysis. As a control, C1s treatment of EPCR did not affect its binding to full-length PfEMP1 ectodomains (hashed boxes).

Article Snippet: Plastic plates were spotted with 5 μL of EPCR (13320-H02H; Sino Biologicals), CSA (a gift from Dr. Michal Fried, NIAID/NIH, Bethesda, MD), CD36 (1955-CD; R&D Systems), or ICAM-1 (720-IC; R&D Systems); all recombinant proteins, except for ICAM-1 which was used at 100 μg/mL, were at a concentration of 50 μg/mL.

Techniques: Recombinant, SDS Page, Binding Assay, Enzyme-linked Immunosorbent Assay, Activity Assay, Control